Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Rohto Pharmaceutical Co., Ltd. (4527:JPX), powered by AI.
Rohto Pharmaceutical Co., Ltd. is currently trading at ¥2,279. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Rohto Pharmaceutical Co., Ltd. on Alpha Lenz.
Rohto Pharmaceutical Co., Ltd.'s P/E ratio is 16.7.
“Rohto Pharmaceutical Co., Ltd. trades at a P/E of 16.7 (fair value) with solid ROE of 12.2%. 3Y revenue CAGR of 15.6% highlights clear growth momentum.”
Ask for details →Rohto Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical industry, specializing in the research, development, and distribution of a diverse range of health and wellness products. Established in Japan, the company has gained recognition for its innovative solutions in skincare, internal health, and general wellness. Rohto's primary function is to cater to the evolving needs of consumers seeking advanced therapeutic options and everyday health maintenance products. The company's extensive product line includes over-the-counter medications, skincare items like acne treatments and anti-aging creams, and eye care solutions such as soothing eye drops. Additionally, Rohto is renowned for its mentholated products, which offer relief for minor aches and nasal congestion. The firm operates not just locally but on a global scale, extending its reach into international markets and contributing significantly to the healthcare sector. Rohto Pharmaceutical Co., Ltd. plays a crucial role in the provision of accessible healthcare solutions, adapting to consumer preferences with continuous research advancements and product enhancements. It holds significant market influence, underpinned by its commitment to enhancing quality of life through innovative and reliable health products.
“Rohto Pharmaceutical Co., Ltd. trades at a P/E of 16.7 (fair value) with solid ROE of 12.2%. 3Y revenue CAGR of 15.6% highlights clear growth momentum.”
Ask for details →Rohto Pharmaceutical Co., Ltd. (ticker: 4527) is a company listed on JPX in the Consumer Defensive sector (Household & Personal Products). It has approximately 9,144 employees. Market cap is $519.2B.
The current price is 2,279 with a P/E ratio of 16.74x and P/B of 2x.
ROE is 12.24% and operating margin is 12.62%. Annual revenue is $308.6B.